Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT03256240
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- side-to-side functional end anastomosis — OTHERtype of anastomosis
- Kono-S analstomosis — OTHERantimesenteric anastomosis
Study Details
This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective trial. Patients with Crohn's ileitis or Crohn's ileocolitis requiring resection will be randomized to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.
Key Dates
- Start date
- Mar 12, 2014
- Status verified
- May 2026
- Primary completion
- Jul 31, 2030
- Completion
- Dec 31, 2036
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: side-to-side functional end anastomosisside-to-side functional end anastomosis creation
- Active Comparator: Kono-Santimesenteric functional side-to-side handsewn anastomosis, known as the Kono-S anastomosis
Primary Outcome Measure
Post-operative endoscopic remission of Crohn's disease between 3 and 6 months after surgery [ Time Frame: 3-6 months after surgery ]
Central Contacts
- Koianka Trencheva, Dr.PH,BSN,MS646-962-2342
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
| Weill Cornell Medical College | New York | New York | 10065 | |
| University of Oklahoma | Oklahoma City | Oklahoma | 73112 | - |
| Baylor Scott & White Research Institute | Dallas | Texas | 75204 | - |
| Baylor College of Medicine | Houston | Texas | 77030 | - |
| University of Washington Medical Center | Seattle | Washington | 98195 | - |
Find similar trials in Boston, MA
By condition
Related Studies
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)PHASE3 · Recruiting · Eli Lilly and Company · San Francisco, California
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)PHASE3 · Recruiting · Takeda · Mobile, Alabama
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseasePHASE3 · Recruiting · Eli Lilly and Company · Los Angeles, California